Mevis Medical Solutions AG
XETRA:M3V

Watchlist Manager
Mevis Medical Solutions AG Logo
Mevis Medical Solutions AG
XETRA:M3V
Watchlist
Price: 24.8 EUR Market Closed
Market Cap: 45.1m EUR

Mevis Medical Solutions AG
Income from Continuing Operations

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Mevis Medical Solutions AG
Income from Continuing Operations Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
Mevis Medical Solutions AG
XETRA:M3V
Income from Continuing Operations
€4.6m
CAGR 3-Years
0%
CAGR 5-Years
-11%
CAGR 10-Years
1%
CompuGroup Medical SE & Co KgaA
XETRA:COP
Income from Continuing Operations
€27.4m
CAGR 3-Years
-29%
CAGR 5-Years
-14%
CAGR 10-Years
-4%
Nexus AG
XETRA:NXU
Income from Continuing Operations
€34m
CAGR 3-Years
19%
CAGR 5-Years
21%
CAGR 10-Years
14%
DocCheck AG
XETRA:AJ91
Income from Continuing Operations
€5.3m
CAGR 3-Years
-24%
CAGR 5-Years
11%
CAGR 10-Years
12%
CHAPTERS Group AG
XETRA:CHG
Income from Continuing Operations
-€19.9m
CAGR 3-Years
N/A
CAGR 5-Years
-31%
CAGR 10-Years
N/A
No Stocks Found

Mevis Medical Solutions AG
Glance View

Market Cap
45.1m EUR
Industry
Health Care

MeVis Medical Solutions AG engages in the provision of software for the analysis and processing of image data. The company is headquartered in Bremen, Bremen and currently employs 103 full-time employees. The company went IPO on 2007-11-16. The firm develops medical application software for industrial customers including turnkey applications, and also research laboratories. In addition to that, the Company operates an online academy and trains professionals, such as radiologists, in working with its products. The firm's software applications support various applicable imaging modalities, especially magnetic resonance tomography (MRT) and digital mammography, but also computer tomography (CT), tomosynthesis and digital sonography based on ultrasonics.

M3V Intrinsic Value
31.07 EUR
Undervaluation 20%
Intrinsic Value
Price

See Also

What is Mevis Medical Solutions AG's Income from Continuing Operations?
Income from Continuing Operations
4.6m EUR

Based on the financial report for Sep 30, 2024, Mevis Medical Solutions AG's Income from Continuing Operations amounts to 4.6m EUR.

What is Mevis Medical Solutions AG's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
1%

Over the last year, the Income from Continuing Operations growth was -7%.

Back to Top